Related Experiment Videos
Prenatal detection of Hb mutations using transcervical cells
M Adinolfi1, N el-Hashemite, J Sherlock
1Galton Laboratory, University College London, U.K.
Prenatal Diagnosis
|June 1, 1997
Summary
Prenatal diagnosis using transcervical cells (TCCs) shows promise for detecting hemoglobin (Hb) mutations early. This method achieved concordance with chorionic villus sampling (CVS) in four out of six cases tested.
Area of Science:
- Medical Genetics
- Prenatal Diagnostics
- Molecular Biology
Background:
- Hemoglobin (Hb) mutations can cause serious inherited blood disorders.
- Accurate and early prenatal diagnosis is crucial for genetic counseling and management.
- Current methods like chorionic villus sampling (CVS) are invasive.
Purpose of the Study:
- To evaluate the feasibility of using transcervical cells (TCCs) for prenatal diagnosis of Hb mutations.
- To compare the diagnostic accuracy of TCCs with established methods like CVS.
Main Methods:
- Prenatal diagnosis was performed on six pregnant mothers carrying Hb mutations.
- Transcervical cells (TCCs) were retrieved from cervical mucus at 10-12 weeks gestation.
- TCCs were compared with cells obtained from chorionic villus sampling (CVS).
Main Results:
- A concordance was observed between TCC testing and CVS results in four out of six cases.
- This suggests TCCs can potentially yield comparable diagnostic information to CVS.
Conclusions:
- Transcervical cell analysis represents a potential non-invasive or less invasive alternative for prenatal screening of hemoglobinopathies.
- Further research with larger cohorts is warranted to confirm the efficacy and reliability of TCC-based prenatal diagnosis.